Attenuation of delayed-type hypersensitivity by fullerene treatment

Toxicology

Volumn 261, Issue 1-2, 2009, Pages 19-24

  Yamashita, Keichiro ^a   Sakai, Masanobu ^a   Takemoto, Naoya ^a   Tsukimoto, Mitsutoshi ^a   Uchida, Katsumi ^a   Yajima, Hiroshi ^a   Oshio, Shigeru ^b   Takeda, Ken ^a   Kojima, Shuji ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

^b OHU UNIVERSITY   (Japan)

Author keywords

Attenuation; Delayed type hypersensitivity (DTH); Nano fullerene (nano C60)

Indexed keywords

BOVINE SERUM ALBUMIN; CRYSTALLIN; CYTOKINE; FULLERENE; INTERLEUKIN 6; NANOPARTICLE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CELL CULTURE; COLLOID; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DOWN REGULATION; EDEMA; FEMALE; FOOT PAD; IMMUNIZATION; IN VITRO STUDY; INFLAMMATION; MOUSE; NANOTECHNOLOGY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN CELL; TH1 CELL; UPREGULATION;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; FULLERENES; HYPERSENSITIVITY, DELAYED; IMMUNOLOGIC FACTORS; INFLAMMATION; INFLAMMATION MEDIATORS; INJECTIONS, INTRAVENOUS; INTERLEUKIN-17; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; NANOPARTICLES; SERUM ALBUMIN, BOVINE; SPLEEN; T-LYMPHOCYTES, REGULATORY; TH1 CELLS;

BOVINAE; MUS;

EID: 66049089521     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2009.04.034     Document Type: Article

References (41)

1. Afzali B., Lombardi G., Lechler R.I., and Lord G.M. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin. Exp. Immunol. 148 1 (2007) 32-46
2. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., and Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature 441 (2006) 235-238
3. Black C.A. Delayed type hypersensitivity: current theories with an historic perspective. Dermatol. Online J. 5 (1999) 1-7
4. Bosi S., Da Ros T., Spalluto G., and Prato M. Fullerene derivatives: an attractive tool for biological applications. Eur. J. Med. Chem. 38 (2003) 913-923
5. Briviba K., Klotz L.O., and Sies H. Toxic and signaling effects of photochemically or chemically generated singlet oxygen in biological systems. Biol. Chem. Hoppe-Seyler 378 (1997) 1259-1265
6. Brown D.M., Wilson M.R., MacNee W., Stone V., and Donaldson K. Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol. Appl. Pharmacol. 175 (2001) 191-199
7. Caspi R.R., Chan C.C., Grubbs B.G., Silver P.B., Wiggert B., Parsa C.F., Bahmanyar S., Billiau A., and Heremans H. Endogenous systemic IFN-gamma has a protective role against ocular autoimmunity in mice. J. Immunol. 152 (1994) 890-899
8. Charlton B., and Lafferty K.J. The Th1/Th2 balance in autoimmunity. Curr. Opin. Immunol. 7 (1995) 793-798
9. Da Ros T., and Prato M. Medicinal chemistry with fullerenes and fullerene derivatives. Chem. Commun. (1999) 663-669
10. 70 in water, preparation and characterization. Langmuir 17 19 (2001) 6013-6017
11. Diaz-Sanchez D. The role of diesel exhaust particles and their associated polyaromatic hydrocarbons in the induction of allergic airway disease. Allergy 52 (1997) 52-58
12. Diaz-Sanchez D., Tsien A., Fleming J., and Saxon A. Combined diesel exhaust particulate and ragweed allergen challenge markedly enhances human in vivo nasal ragweed-specific IgE and skews cytokine production to a T helper cell 2-type pattern. J. Immunol. 158 (1997) 2406-2413
13. Emerich D.F., and Thanos C.G. Nanotechnology and medicine. Expert Opin. Biol. Ther. 3 (2003) 655-663
14. Ferber I.A., Brocke S., Taylor-Edwards C., Ridgway W., Dinisco C., Steinman L., Dalton D., and Fathman C.G. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156 (1996) 5-7
15. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4 (2003) 330-336
16. Fujimaki H., Saneyoshi K., Shiraishi F., Imai T., and Endo T. Inhalation of diesel exhaust enhances antigen-specific IgE antibody production in mice. Toxicology 116 (1997) 227-233
17. Furuzawa-Carballeda J., Vargas-Rojas M.I., and Cabral A.R. Autoimmune inflammation from the Th17 perspective. Autoimmunity Rev. 6 (2007) 69-75
18. 60 fullerene derivatives. Accounts Chem. Res. 33 10 (2000) 695-703
19. Haley K.J., and Drazen J.M. Inflammation and airway function in asthma: what you see is not necessarily what you get. Am. J. Resp. Crit. Care Med. 157 (1998) 1-3
20. Harrington L.E., Mangan P.R., and Weaver C.T. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr. Opin. Immunol. 18 (2006) 349-356
21. Ichinose T., Furuyama A., and Sagai M. Biological effects of diesel exhaust particles (DEP). II. Acute toxicity of DEP introduced into lung by intratracheal instillation. Toxicology 99 (1995) 153-167
22. Jones L.S., Rizzo L.V., Agarwal R.K., Tarrant T.K., Chan C.C., Wiggert B., and Caspi R.R. IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. J. Immunol. 158 (1997) 5997-6005
23. Kariyone, A., Tamura, T., Kano, H., Iwakura, Y., Takeda, K., Akira, S., Takatsu, K., Immunogenicity of peptide-25 of Ag85B in Th1 development: role of IFN-gamma. Int. Immunol. 15, 1183-1194.
24. Kobayashi K., Kanedam K., and Kasamam T. Immunopathogenesis of delayed-type hypersensitivity. Microsc. Res. Tech. 53 (2001) 241-245
25. 60: Buckminsterfullerene. Nature 318 (1985) 162-163
26. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., Hatton R.D., Wahl S.M., Schoeb T.R., and Weaver C.T. Transforming growth factor-beta induces development of the Th17 lineage. Nature 441 (2006) 231-234
27. Moghimi S.M., Hunter A.C., and Murray J.C. Nanomedicine: current status and future prospects. J. Fed. Am. Soc. Exp. Biol. 19 (2005) 311-330
28. Nakae S., Komiyama Y., Nambu A., Sudo K., Iwase M., Homma I., Sekikawa K., Asano M., and Iwakura Y. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17 (2002) 375-387
29. 60) induce oxidative stress in the brain of juvenile largemouth bass. Environ. Health. Persp. 112 (2004) 1058-1062
30. Oberdörster G., Oberdörster E., and Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health. Persp. 113 (2005) 823-839
31. Osawa, E., 1970. Fullerene. Kagaku. 25, 854-863.
32. Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Ann. Rev. Immunol. 22 (2004) 531-562
33. Sato K., Suematsu A., Okamoto K., Yamaguchi A., Morishita Y., Kadono Y., Tanaka S., Kodama T., Akira S., Iwakura Y., Cua D.J., and Takayanagi H. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 203 (2006) 2673-2682
34. 60), a novel carbon allotrope, and its derivatives. J. Pharmacol. Sci. 100 (2006) 513-518
35. 60 cytotoxicity is due to lipid peroxidation. Biomaterials 26 (2005) 7587-7595
36. Särnstrand B., Jansson A.H., Matuseviciene G., Scheynius A., Pierrou S., and Bergstrand H. N,N′-Diacetyl-l-cystine-the disulfide dimer of N-acetylcysteine is a potent modulator of contact sensitivity/delayed type hypersensitivity reactions in rodents. J. Pharmacol. Exp. Ther. 288 (1999) 1174-1184
37. Tagmatarchis N., and Shinohara H. Fullerenes in medicinal chemistry and their biological applications. Mini Rev. Med. Chem. 1 (2001) 339-348
38. Takano H., Yoshikawa T., Ichinose T., Miyabara Y., Imaoka K., and Sagai M. Diesel exhaust particles enhance antigen-induced airway inflammation and local cytokine expression in mice. Am. J. Resp. Crit. Care Med. 156 (1997) 36-42
39. Tanaka S., and Sakaguchi S. Regulatory T cell and autoimmune diseases. Jpn. J. Immunol. 28 (2005) 291-299
40. Vicki L.C. Characterizing the potential risks posed by engineered nanoparticles. Nat. Biotechnol. 21 (2003) 1166-1170
41. Yoshimoto T., Wang C.R., Yoneto T., Matsuzawa A., Cruikshank W.W., and Nariuchi H. Role of IL-16 in delayed-type hypersensitivity reaction. Blood 95 (2000) 2869-2874